Insulin Degludec vs Insulin Glargine for Glycemic Control in Critical Illness Hyperglycemia

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

May 25, 2024

Study Completion Date

June 1, 2024

Conditions

Glycemic ControlInsulinCritical Illness

Interventions

DRUG

Insulin Glargine

hyperglycemic control

DRUG

Insulin Degludec

hyperglycemic control

DRUG

Insulin regular

hyperglycemic control

Trial Locations (1)

Ain shams university, Cairo

All Listed Sponsors

lead

Ain Shams University

OTHER

NCT06178874 - Insulin Degludec vs Insulin Glargine for Glycemic Control in Critical Illness Hyperglycemia | Biotech Hunter | Biotech Hunter